Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

7LF3

C1B domain of Protein kinase C in complex with diacylglycerol-lactone AJH-836

Summary for 7LF3
Entry DOI10.2210/pdb7lf3/pdb
DescriptorProtein kinase C delta type, ZINC ION, {(2R,4E)-2-(hydroxymethyl)-4-[5-methyl-3-(2-methylpropyl)hexylidene]-5-oxooxolan-2-yl}methyl 2,2-dimethylpropanoate, ... (5 entities in total)
Functional Keywordsc1, lipid-binding, diacylglycerol-binding, zn2+ finger, lipid binding protein
Biological sourceRattus norvegicus (Rat)
Total number of polymer chains1
Total formula weight7093.14
Authors
Katti, S.S.,Krieger, I.V. (deposition date: 2021-01-15, release date: 2022-05-04, Last modification date: 2023-10-18)
Primary citationKatti, S.S.,Krieger, I.V.,Ann, J.,Lee, J.,Sacchettini, J.C.,Igumenova, T.I.
Structural anatomy of Protein Kinase C C1 domain interactions with diacylglycerol and other agonists.
Nat Commun, 13:2695-2695, 2022
Cited by
PubMed Abstract: Diacylglycerol (DAG) is a versatile lipid whose 1,2-sn-stereoisomer serves both as second messenger in signal transduction pathways that control vital cellular processes, and as metabolic precursor for downstream signaling lipids such as phosphatidic acid. Effector proteins translocate to available DAG pools in the membranes by using conserved homology 1 (C1) domains as DAG-sensing modules. Yet, how C1 domains recognize and capture DAG in the complex environment of a biological membrane has remained unresolved for the 40 years since the discovery of Protein Kinase C (PKC) as the first member of the DAG effector cohort. Herein, we report the high-resolution crystal structures of a C1 domain (C1B from PKCδ) complexed to DAG and to each of four potent PKC agonists that produce different biological readouts and that command intense therapeutic interest. This structural information details the mechanisms of stereospecific recognition of DAG by the C1 domains, the functional properties of the lipid-binding site, and the identities of the key residues required for the recognition and capture of DAG and exogenous agonists. Moreover, the structures of the five C1 domain complexes provide the high-resolution guides for the design of agents that modulate the activities of DAG effector proteins.
PubMed: 35577811
DOI: 10.1038/s41467-022-30389-2
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.13 Å)
Structure validation

227344

PDB entries from 2024-11-13

PDB statisticsPDBj update infoContact PDBjnumon